Drug Type Antibody drug conjugate (ADC) |
Synonyms TB ADC 02 |
Target |
Mechanism CEACAM5 antagonists(Carcinoembryonic antigen related cell adhesion molecule 5 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Theragen Bio Co., Ltd.Startup |
Active Organization Theragen Bio Co., Ltd.Startup |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Rectal Cancer | Discovery | KR | Theragen Bio Co., Ltd.Startup | 14 May 2024 |